Fate Therapeutics (FATE) Receivables - Net (2015 - 2026)

Fate Therapeutics' Receivables - Net history runs 10 years deep, the most recent figure standing at $704000.0 for Q1 2026.

• Quarterly Receivables - Net fell 70.74% year-over-year to $704000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $704000.0 (down 70.74% YoY) and the FY2025 annual result came in at $916000.0, down 74.12% from the prior year.
• Receivables - Net was $704000.0 for Q1 2026 at Fate Therapeutics, down from $916000.0 in the prior quarter.
• Across five years, Receivables - Net topped out at $38.5 million in Q4 2022 and bottomed at $682000.0 in Q3 2025.
• A 5-year average of $6.5 million and a median of $2.4 million in 2025 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2022 — Receivables - Net soared 343.52% — and 2023, when it tumbled 95.25%.
• Fate Therapeutics' Receivables - Net stood at $38.5 million in 2022, then tumbled by 95.25% to $1.8 million in 2023, then jumped by 93.81% to $3.5 million in 2024, then plunged by 74.12% to $916000.0 in 2025, then decreased by 23.14% to $704000.0 in 2026.
• Business Quant data shows FATE's Receivables - Net at $704000.0 in Q1 2026, $916000.0 in Q4 2025, and $682000.0 in Q3 2025.